Current position:Home >Product >
		
		
	
N-cyclohexyl-2-(2-methoxyethyl)-3-(1-methylindol-3-yl)-1-oxidanylidene-3,4-dihydroisoquinoline-4-carboxamide
N-cyclohexyl-2-(2-methoxyethyl)-3-(1-methylindol-3-yl)-1-oxidanylidene-3,4-dihydroisoquinoline-4-carboxamide
		
  | 
      
	   
		
		   | 
      
Canonical SMILES:
CN1C=C(C2=CC=CC=C21)C3C(C4=CC=CC=C4C(=O)N3CCOC)C(=O)NC5CCCCC5
Isomeric SMILES
CN1C=C(C2=CC=CC=C21)C3C(C4=CC=CC=C4C(=O)N3CCOC)C(=O)NC5CCCCC5
InChI
InChI=1S/C28H33N3O3/c1-30-18-23(20-12-8-9-15-24(20)30)26-25(27(32)29-19-10-4-3-5-11-19)21-13-6-7-14-22(21)28(33)31(26)16-17-34-2/h6-9,12-15,18-19,25-26H,3-5,10-11,16-17H2,1-2H3,(H,29,32)
      
		
	   Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
 - 2,5-bis(chloranyl)benzene-1,4-diol
 - 2,5-bis(chloranyl)phenol
 - 2-oxidanylidenehexanedioic acid
 - 2-oxidanylidene-3-sulfanyl-propanoic acid
 - 3-oxidanylbenzaldehyde
 - 3-azanylpropanal
 - 2-azanyl-3-oxidanyl-benzoic acid
 - 3-(3-hydroxyphenyl)propanoic acid
 - 3-oxidanylidenehexanedioic acid
 - N-(2-chloranyl-4-methyl-phenyl)-2-(2-methoxyethyl)-3-(1-methylindol-3-yl)-1-oxidanylidene-3,4-dihydroisoquinoline-4-carboxamide
 - 2-(2-methoxyethyl)-3-(1-methylindol-3-yl)-1-oxidanylidene-N-(pyridin-3-ylmethyl)-3,4-dihydroisoquinoline-4-carboxamide
 - N-(2-bromophenyl)-4-(4-methoxyphenyl)-2,4-bis(oxidanylidene)butanamide
 - N-(5-methyl-7-oxidanylidene-1H-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)thiophene-2-carboxamide
 - 2-(2-methoxyethyl)-N-(3-methylbutyl)-3-(1-methylindol-3-yl)-1-oxidanylidene-3,4-dihydroisoquinoline-4-carboxamide
 - N-[(4-fluorophenyl)methyl]-2-(2-methoxyethyl)-3-(1-methylindol-3-yl)-1-oxidanylidene-3,4-dihydroisoquinoline-4-carboxamide
 - 4-[4-(2,5-dimethylphenyl)piperazin-1-yl]carbonyl-2-(2-methoxyethyl)-3-(1-methylindol-3-yl)-3,4-dihydroisoquinolin-1-one
 - 7-methoxy-N-(4-phenoxyphenyl)thieno[2,3-b]quinoline-2-carboxamide
 - (7-methylthieno[2,3-b]quinolin-2-yl)-[4-(4-nitrophenyl)piperazin-1-yl]methanone
 - N,7-dimethyl-N-[3-(trifluoromethyl)phenyl]thieno[2,3-b]quinoline-2-carboxamide
 

               
       